Become a Distributor

ESWT For Orthopedic Use

Efficacy of Extracorporeal Shock Wave Therapy - Regenomedix

Recent Studies & Publications

logo
RegenOMedix™, a division of Zizion® Group, is an FDA-registered medical device distributor offering products for Hair Regeneration, Aesthetics , Orthopedics, Sexual Wellness, and Wound Healing.
Become A Distributor
Quick Links
Get in touch

© 2025 RegenOMedix™ |  All Rights Reserved  |  Powered by NWOL | Privacy Policy

Disclaimer: The Food and Drug Administration has not evaluated the statements made on this website. These statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Performance Data

510(k) equivalence study conducted and the following mean results were achieved:

  • Platelet Concentration Factor at 0 Hours = 4.1 – 4.5x baseline
  • Platelet Concentration Factor at 1 Hour = 4.5 – 4.8x baseline
  • Platelet Recovery % at 1 Hour = 61%
  • RBC at 0 Hours = 0.01
  • RBC at 4 Hours = 0.01
  • pH at 0 Hours = 7.5
  • pH at 4 Hours = 7.65
  • Platelet Activation (Resting) at 0 Hours = 10.2%
  • Platelet Activation (Stimulated ADP) at 0 Hours = 96.3%
  • Platelet Aggregation at 0 Hours = 96.1%
  • Platelet Aggregation at 4 Hours = 95.8%
  • HCT at 0 Hours = 0.01%
  • HCT at 4 Hours = 0.01%
  • WBC at 0 Hours = 0.6
  • WBC at 4 Hours = 0.6